Skip to content

Menu

LexBlog, Inc. logo
NetworkSub-MenuBrowse by SubjectBrowse by PublisherJoin the NetworkGet StartedSubscribeSupportContact
Search
Close

Makary must stop the bleeding if confirmed to lead FDA

By Dr. Peter G. Lurie on March 5, 2025
Email this postTweet this postLike this postShare this post on LinkedIn
Marty Makary
Marty Makary

— OPINION —

If I were a Senator conducting a confirmation hearing for Dr. Marty Makary, the nominee to be the next commissioner of the Food and Drug Administration, my first question to him would be: ‘Who, in fact, will be running this agency? You, Dr. Makary? Or Elon Musk and his unaccountable team of technocrats?’

The legally dubious “Department of Government Efficiency,” has taken a flamethrower to the staff directory at FDA, summarily dismissing staff freshly hired to deal with the safety of infant formula, to respond to foodborne outbreaks, and to review the safety of chemicals used in our food, among other things.

If Makary is confirmed, job number one is going to be to stop the bleeding of staff with the scientific expertise to keep our food and drugs safe, and to resist an additional round of cuts the administration has asked agencies to propose later this month.

These arbitrary and reckless cuts aren’t going to make any Americans healthier. Instead, they will increase the likelihood of foodborne illness outbreaks and increase the time necessary for FDA to solve them. Moreover, if Dr. Makary is, like Secretary Kennedy, concerned with the safety of food additives and dyes, following through with arbitrary, sweeping DOGE cuts will make it harder for the agency to address them.

If Dr. Makary hopes to help Americans avoid chronic conditions like diabetes and heart disease, he could start by continuing the agency’s work on front-of-package nutrition labeling, and on reducing sodium in the food supply. That will take staff. If he wants to ensure that chemicals in our food are safe, he will move to close the Generally Recognized as Safe loophole and advance FDA’s post-market assessment initiative. And he’d leave FDA’s new rule on laboratory-developed tests intact.

Finally, if Dr. Makary wants to help Americans avoid communicable disease, he must not succumb to the extreme, anti-vaccination ideology percolating from elsewhere in the administration. It’s bad enough to have a measles outbreak in the year 2025. We shouldn’t have to worry about a possible polio outbreak in the year 2026, or a pertussis outbreak in 2027.

(To sign up for a free subscription to Food Safety News,click here)

Photo of Dr. Peter G. Lurie Dr. Peter G. Lurie

Peter Lurie, M.D., M.P.H., is president of the Center for Science in the Public Interest, a nonprofit health advocacy group based in Washington, DC, that focuses on nutrition and food safety policies. Previously, Lurie was the associate commissioner for Public Health Strategy…

Peter Lurie, M.D., M.P.H., is president of the Center for Science in the Public Interest, a nonprofit health advocacy group based in Washington, DC, that focuses on nutrition and food safety policies. Previously, Lurie was the associate commissioner for Public Health Strategy and Analysis at the Food and Drug Administration.

While at FDA he worked on antimicrobial resistance, transparency, caffeinated beverages, arsenic in rice, fish consumption by pregnant and nursing women, expanded access to investigational drugs, and prescription drug abuse. Prior to that, he was deputy director of Public Citizen’s Health Research Group.  Earlier, he was a faculty member at the University of California-San Francisco and the University of Michigan.

Email
Show more Show less
  • Posted in:
    Food, Drug & Agriculture, Health Care and Life Sciences
  • Blog:
    Food Safety News
  • Organization:
    Marler Clark, Inc., PS
  • Article: View Original Source

Call us at 1-800-913-0988 or email sales@lexblog.com.

Facebook LinkedIn Twitter RSS
The Library at LexBlog
  • About LexBlog
  • The Field We Built
  • Library at LexBlog
  • Our Beliefs
  • Our Team
  • Contact LexBlog
  • Disclaimer
  • Editorial Policy
  • Terms of Service
  • Get Started
  • Publishing Solutions
  • Compass
  • Submit a Request
  • Support Center
  • System Status
Copyright © 2026, LexBlog, Inc. All Rights Reserved.
Law blog design & platform by LexBlog LexBlog Logo